Open AccessAnlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma
Author(s) -
Man Jiang,
Chuantao Zhang,
Yabin Hu,
Tianjun Li,
Guangjie Yang,
Guanqun Wang,
Jingjuan Zhu,
Changfeng Shao,
Helei Hou,
Na Zhou,
Kewei Liu,
Xiaochun Zhang
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac136
Subject(s) - medicine , regimen , gastroenterology , cd8 , oncology , adverse effect , antigen , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom